Amplifon S.p.A Change in Accounts Receivable 2019-2024 | AMFPF

Amplifon S.p.A annual/quarterly change in accounts receivable history and growth rate from 2019 to 2024. Change in accounts receivable can be defined as the increase or decrease in accounts receivable for the given period.
  • Amplifon S.p.A change in accounts receivable for the quarter ending September 30, 2024 was $-0.001B, a 101.6% decline year-over-year.
  • Amplifon S.p.A change in accounts receivable for the twelve months ending September 30, 2024 was $0.004B, a 92.52% decline year-over-year.
  • Amplifon S.p.A annual change in accounts receivable for 2024 was $0.003B, a 106.38% decline from 2023.
  • Amplifon S.p.A annual change in accounts receivable for 2023 was $-0.053B, a 124.2% increase from 2022.
  • Amplifon S.p.A annual change in accounts receivable for 2022 was $-0.024B, a 764.6% decline from 2021.
Amplifon S.p.A Annual Change in Accounts Receivable
(Millions of US $)
2024 $3
2023 $-53
2022 $-24
2021 $4
2020 $38
2019 $-37
2018 $-28
Sector Industry Market Cap Revenue
Medical Medical Services $5.378B $2.607B
Amplifon SpA provides hearing solutions and services. It operates principally in Italy, France, Spain, Portugal, Switzerland, Austria, Holland, the United States, Hungary and Egypt. Amplifon SpA is based in Milan, Italy.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $146.784B 27.53
Elevance Health (ELV) United States $87.260B 11.26
CVS Health (CVS) United States $83.934B 10.43
Cencora (COR) United States $57.186B 19.90
Natera (NTRA) United States $22.441B 0.00
DiDi Global (DIDIY) China $22.121B 23.50
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.895B 0.00
Solventum (SOLV) United States $12.853B 13.61
ICON (ICLR) Ireland $11.879B 11.04
CochLear (CHEOY) Australia $11.671B 0.00
Revvity (RVTY) United States $11.280B 19.41
Doximity (DOCS) United States $10.697B 49.52
Viatris (VTRS) United States $10.669B 3.67
Avantor (AVTR) United States $9.227B 13.41
HealthEquity (HQY) United States $8.993B 39.39
Medpace Holdings (MEDP) United States $8.737B 23.21
Sonic Healthcare (SKHHY) Australia $8.503B 0.00
Charles River Laboratories (CRL) United States $7.460B 14.62
Bausch + Lomb (BLCO) Canada $4.400B 25.92
BrightSpring Health Services (BTSG) United States $3.797B 34.84
Sotera Health (SHC) United States $3.335B 18.95
Alignment Healthcare (ALHC) United States $2.983B 0.00
Surgery Partners (SGRY) United States $2.961B 38.50
Concentras Parent (CON) United States $2.793B 16.14
Organon (OGN) United States $2.618B 2.78
Ardent Health (ARDT) United States $1.938B 8.26
GeneDx Holdings (WGS) United States $1.894B 72.93
Premier (PINC) United States $1.855B 14.08
Progyny (PGNY) United States $1.847B 40.66
PACS (PACS) United States $1.614B 0.00
GoodRx Holdings (GDRX) United States $1.600B 32.00
Teladoc Health (TDOC) United States $1.258B 0.00
Pediatrix Medical (MD) United States $1.224B 9.31
Establishment Labs Holdings (ESTA) $1.073B 0.00
CareDx (CDNA) United States $1.048B 16.37
Ryman Healthcare (RYHTY) New Zealand $1.011B 0.00
Agilon Health (AGL) United States $0.907B 0.00
AMN Healthcare Services Inc (AMN) United States $0.828B 7.75
QDM (QDMI) Hong Kong, SAR China $0.763B 0.00
Nutex Health (NUTX) United States $0.694B 10.51
Embecta (EMBC) United States $0.587B 3.95
LifeMD (LFMD) United States $0.577B 0.00
Enhabit (EHAB) United States $0.505B 41.54
InnovAge Holding (INNV) United States $0.498B 0.00
Auna S.A (AUNA) Luxembourg $0.469B 10.57
Sonida Senior Living (SNDA) United States $0.467B 0.00
SBC Medicals (SBC) United States $0.464B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.423B 0.00
Performant Healthcare (PHLT) United States $0.257B 0.00
Oncology Institute (TOI) United States $0.236B 0.00
Beauty Health (SKIN) United States $0.197B 0.00
DocGo (DCGO) United States $0.154B 25.17
KindlyMD (KDLY) United States $0.150B 0.00
Pheton Holdings (PTHL) China $0.111B 0.00
KindlyMD (NAKA) United States $0.102B 0.00
So-Young (SY) China $0.095B 0.00
Basel Medical Group (BMGL) Singapore $0.087B 0.00
OncoCyte (OCX) United States $0.077B 0.00
Sera Prognostics (SERA) United States $0.067B 0.00
Ascend Wellness Holdings (AAWH) United States $0.063B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.055B 0.00
ModivCare (MODV) United States $0.048B 0.00
Biodesix (BDSX) United States $0.044B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.029B 0.00
Intelligent Bio Solutions (INBS) United States $0.013B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00